Benzinga | Nov 11, 2021 04:02PM EST

Co-Diagnostics Q3 EPS $0.38 Beats $0.21 Estimate, Sales $30.10M Beat $24.32M Estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.21 by 80.95 percent. This is a 28.3 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $30.10 million which beat the analyst consensus estimate of $24.32 million by 23.77 percent. This is a 37.95 percent increase over sales of $21.82 million the same period last year.